Total Funding
18
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
321532
Autotelic uses therapeutic drug monitoring to enhance the development of therapeutics.
Vuong Trieu: CEOPast Role: Sorrento Therapeutics, BOD & CSO
Osmond D'Cruz: Director of Drug SafetyPast Role: Igdrasol Therapeutics, Held Positions
About the Company
Autotelic uses therapeutic drug monitoring to enhance the development of therapeutics. It is designed to Increase patent life, expand the therapeutic window, and shorten the clinical development path. Autotelic starts companies or invest in existing companies combining our TDM device with the licensed therapeutics to become a winning drug-device
combination. It brings on experts and the experience needed for a successful biotechnology/pharma company. They take company through its logical exit points either M&A or to access the public markets so that sufficient funding is in place to fully develop the drug-device combination.
